Growth Factors for the Treatment of Ischemic Brain Injury (Growth Factor Treatment)
Open Access
- 30 April 2015
- journal article
- review article
- Published by MDPI AG in Brain Sciences
- Vol. 5 (2) , 165-177
Abstract
In recent years, growth factor therapy has emerged as a potential treatment for ischemic brain injury. The efficacy of therapies that either directly introduce or stimulate local production of growth factors and their receptors in damaged brain tissue has been tested in a multitude of models for different Central Nervous System (CNS) diseases. These growth factors include erythropoietin (EPO), vascular endothelial growth factor (VEGF), brain-derived neurotrophic factor (BDNF), and insulin-like growth factor (IGF-1), among others. Despite the promise shown in animal models, the particular growth factors that should be used to maximize both brain protection and repair, and the therapeutic critical period, are not well defined. We will review current pre-clinical and clinical evidence for growth factor therapies in treating different causes of brain injury, as well as issues to be addressed prior to application in humans.Keywords
This publication has 92 references indexed in Scilit:
- Stroke knowledge among diabetics: a cross-sectional study on the influence of age, gender, education, and migration statusBMC Neurology, 2013
- Neuroprotective Role of Nerve Growth Factor in Hypoxic-Ischemic Brain InjuryBrain Sciences, 2013
- The Neuroprotective Effects of Intramuscular Insulin-Like Growth Factor-I Treatment in Brain Ischemic RatsPLOS ONE, 2013
- Post-ischemic continuous infusion of erythropoeitin enhances recovery of lost memory function after global cerebral ischemia in the ratBMC Neuroscience, 2013
- Erythropoietin-induced changes in brain gene expression reveal induction of synaptic plasticity genes in experimental strokeProceedings of the National Academy of Sciences, 2012
- Erythropoietin in Combination of Tissue Plasminogen Activator Exacerbates Brain Hemorrhage When Treatment Is Initiated 6 Hours After StrokeStroke, 2010
- Enhanced Oligodendrogenesis and Recovery of Neurological Function by Erythropoietin After Neonatal Hypoxic/Ischemic Brain InjuryStroke, 2010
- New insights into the role of brain-derived neurotrophic factor in synaptic plasticityMolecular and Cellular Neuroscience, 2009
- Erythropoietin Sustains Cognitive Function and Brain Volume after Neonatal StrokeDevelopmental Neuroscience, 2009
- MRI Identification of White Matter Reorganization Enhanced by Erythropoietin Treatment in a Rat Model of Focal IschemiaStroke, 2009